Here are three reasons why there are better opportunities than MMM and a stock we'd rather own. Producers of the first asthma inhaler, 3M Company (NYSE:MMM) is a global conglomerate known for products ...

Company plans to meet with FDA regarding potential sNDA submission in 1H 2025Call planned today at 8:30 a.m. (ET) to discuss company’s diabetes ...

The news followed an investigation by POLITICO's E&E News into climate-friendly inhalers and how drug giants are developing ...

MILLIONS have been urged to protect themselves a “tidal wave” of flu and winter bugs in the days before Christmas. Eligible ...

As pollution worsens in the Indian capital, parents are facing an impossible choice: stay or go. Amrita Rosha, 45, is among ...

Action is the latest following Baldwin’s investigation into the extremely high prices these companies charge for inhalers ...

Americans with asthma and 16 million Americans with COPD need inhalers to breathe. Vermont Business Magazine Sen. Bernie Sanders (I-Vermont), Chairman of the Senate Com ...

Afrezza, world’s only rapid-acting, inhaled insulin for type 1 & type 2 diabetes patients & manufactured by MannKind, ...

increases risk of asthma attacks and death.[2] The new guidance makes it clear that no patient should be prescribed a SABA ...

The global vibrating mesh nebulizer market is experiencing substantial growth, with a projected increase from US$ 288.1 ...

In recent weeks there has been a buzz around a new treatment breakthrough: benralizumab, which in a study published in the ...

The parent of a student with disabilities has filed a lawsuit against D.C. public schools for its alleged failure to ...